Publication | Open Access

Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds

N-substituted Isatin CompoundsMedicineAntiviral Drug DevelopmentSars-cov-2 3C-like ProteasePotent InhibitorsAntiviral DrugPharmacologyAntiviral CompoundBiomolecular EngineeringDrug Discovery